Harsimar B Kaur (Harsimar Kaur)

Years Active: 2020-2021
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Harsimar B Kaur, Thiago Vidotto, Adrianna A Mendes, Daniela C Salles, William B Isaacs, Emmanuel S Antonarakis, Tamara L Lotan
Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer. Cancer immunology, immunotherapy : CII (2021)
Tamara L Lotan, Harsimar B Kaur, Daniela C Salles, Sanjana Murali, Edward M Schaeffer, Jerry S Lanchbury, William B Isaacs, Robert Brown, Andrea L Richardson, Olivier Cussenot, Geraldine Cancel-Tassin, Kirsten M Timms, Emmanuel S Antonarakis
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (6) (2021)
Harsimar B Kaur, Daniela C Salles, Adina Paulk, Jonathan I Epstein, James R Eshleman, Tamara L Lotan
PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations. Histopathology 78 (2) (2020)
Harsimar B Kaur, Iryna Samarska, Jiayun Lu, Farzana Faisal, Benjamin L Maughan, Sanjana Murali, Kaushal Asrani, Mohamed Alshalalfa, Emmanuel S Antonarakis, Jonathan I Epstein, Corinne E Joshu, Edward M Schaeffer, Juan Miguel Mosquera, Tamara L Lotan
Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance. The Prostate 80 (12) (2020)

Harsimar B Kaur.css-eqlu8i{font-size:small;padding-left:4px;} (Harsimar Kaur)